RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Genetic Signatures Stock

Genetic Signatures ROA 2024

Genetic Signatures ROA

-0.27

Ticker

GSS.AX

ISIN

AU000000GSS4

In 2024, Genetic Signatures's return on assets (ROA) was -0.27, a -617% increase from the 0.05 ROA in the previous year.

Genetic Signatures Aktienanalyse

What does Genetic Signatures do?

Genetic Signatures ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Genetic Signatures's Return on Assets (ROA)

Genetic Signatures's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Genetic Signatures's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Genetic Signatures's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Genetic Signatures’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Genetic Signatures stock

What is the Return on Assets (ROA) of Genetic Signatures this year?

The Return on Assets (ROA) of Genetic Signatures is -0.27 undefined this year.

What was the ROA of Genetic Signatures compared to the previous year?

The ROA of Genetic Signatures has increased by -617% compared to the previous year.

What consequences do high ROA have for investors of Genetic Signatures?

A high ROA is advantageous for investors of Genetic Signatures, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Genetic Signatures?

A low ROA can be unfavorable for investors of Genetic Signatures as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Genetic Signatures affect the company?

An increase in ROA of Genetic Signatures can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Genetic Signatures impact the company?

A reduction in the ROA of Genetic Signatures can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Genetic Signatures?

Some factors that can influence the ROA of Genetic Signatures include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Genetic Signatures important for investors?

The ROA of Genetic Signatures is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Genetic Signatures take to improve ROA?

To improve ROA, Genetic Signatures can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Genetic Signatures pay?

Over the past 12 months, Genetic Signatures paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genetic Signatures is expected to pay a dividend of 0 AUD.

What is the dividend yield of Genetic Signatures?

The current dividend yield of Genetic Signatures is .

When does Genetic Signatures pay dividends?

Genetic Signatures pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Genetic Signatures?

Genetic Signatures paid dividends every year for the past 0 years.

What is the dividend of Genetic Signatures?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Genetic Signatures located?

Genetic Signatures is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genetic Signatures kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genetic Signatures from 11/17/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.

When did Genetic Signatures pay the last dividend?

The last dividend was paid out on 11/17/2024.

What was the dividend of Genetic Signatures in the year 2023?

In the year 2023, Genetic Signatures distributed 0 AUD as dividends.

In which currency does Genetic Signatures pay out the dividend?

The dividends of Genetic Signatures are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Genetic Signatures

Our stock analysis for Genetic Signatures Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genetic Signatures Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.